Armed with $6.3 million in new pre-seed capital, Synonym Biotechnologies has begun the development phase for its first productized bio-manufacturing facilities for non-pharmaceutical applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback